Laura Algeri

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols.

Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols.

Journal: Psycho-oncology

Published: March 04, 2025

Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers.

Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers.

Journal: ESMO open

Published: July 07, 2024

Clinical/pathological features and survival outcomes of extra-pulmonary neuroendocrine carcinomas: A retrospective single-center series.

Clinical/pathological features and survival outcomes of extra-pulmonary neuroendocrine carcinomas: A retrospective single-center series.

Journal: Journal of neuroendocrinology

Published: June 15, 2024

Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?

Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?

Journal: Journal for immunotherapy of cancer

Published: April 11, 2024

Venous thromboembolism in pancreatic neuroendocrine neoplasm: a cohort study.

Venous thromboembolism in pancreatic neuroendocrine neoplasm: a cohort study.

Journal: Research and practice in thrombosis and haemostasis

Published: February 12, 2024

Promising targetable biomarkers in pancreatic neuroendocrine tumours.

Promising targetable biomarkers in pancreatic neuroendocrine tumours.

Journal: Expert review of endocrinology & metabolism

Published: September 25, 2023

Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.

Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.

Journal: Endocrine-related cancer

Published: June 27, 2023

KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.

KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.

Journal: The oncologist

Published: April 04, 2023

Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab.

Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab.

Journal: Frontiers in oncology

Published: January 10, 2023

Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors.

Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors.

Journal: Cancers

Published: November 22, 2022

Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvement.

Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvement.

Journal: Therapeutic advances in medical oncology

Published: November 09, 2021

Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).

Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).

Journal: Therapeutic advances in medical oncology

Published: May 02, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026